{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:13:34Z","timestamp":1793909614149,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejmech.2025.117726","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:09:09Z","timestamp":1746558549000},"page":"117726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Bicyclic 2-aminopyrimidine derivatives as potent VEGFR-2 inhibitors and apoptosis Inducers: Structure-Guided design, synthesis, anticancer assessment, and in-silico exploration"],"prefix":"10.1016","volume":"293","author":[{"given":"Arshma","family":"Siddique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muzzammel","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2419-3172","authenticated-orcid":false,"given":"Umer","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117726_bib1","article-title":"Synthesis, pharmacological evaluation and molecular modelling studies of pregnenolone derivatives as inhibitors of human dihydrofolate reductase","volume":"168","author":"Tufail","year":"2021","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2025.117726_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128668","article-title":"Rational design, synthesis, antiproliferative activity against MCF-7, MDA-MB-231 cells, estrogen receptors binding affinity, and computational study of indenopyrimidine-2, 5-dione analogs for the treatment of breast cancer","volume":"64","author":"Ejaz","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117726_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.117726_bib4","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.1021\/acs.jmedchem.1c01168","article-title":"Development of novel VEGFR2 inhibitors originating from natural product analogues with antiangiogenic impact","volume":"64","author":"Cho","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib5","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1016\/j.bmc.2018.05.046","article-title":"Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase","volume":"26","author":"Taha","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bioorg.2018.05.026","article-title":"Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines","volume":"80","author":"Iftikhar","year":"2018","journal-title":"B Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/ml5000417","article-title":"Discovery of a new series of naphthamides as potent VEGFR-2 kinase inhibitors","volume":"5","author":"Lv","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117726_bib8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/acsmedchemlett.4c00095","article-title":"Insight on some newly synthesized trisubstituted imidazolinones as VEGFR-2 inhibitors","volume":"15","author":"Mohamed","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117726_bib9","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1080\/14756366.2021.1945591","article-title":"Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies","volume":"36","author":"Alanazi","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib10","article-title":"Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy","author":"Liu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116472","article-title":"Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions","author":"Thakur","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3390\/biom10121673","article-title":"Structural basis for vascular endothelial growth factor receptor activation and implications for disease therapy","volume":"10","author":"Shaik","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.117726_bib13","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/ijms19041232","article-title":"Resistance to anti-angiogenic therapy in Cancer\u2014Alterations to anti-VEGF pathway","volume":"19","author":"Itatani","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117726_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117404","article-title":"Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitors","volume":"91","author":"Hou","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib15","article-title":"Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: biological activity and structural activity relationship","author":"Jha","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib16","doi-asserted-by":"crossref","first-page":"10797","DOI":"10.1021\/jm301085w","article-title":"Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors","volume":"55","author":"Musumeci","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/156800911795655985","article-title":"VEGF\/VEGFR pathway inhibitors as anti-angiogenic agents: present and future","volume":"11","author":"Sharma","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2025.117726_bib18","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2174\/092986707782023622","article-title":"Antiangiogenic agents: an update on small molecule VEGFR inhibitors","volume":"14","author":"Schenone","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00044-014-1120-z","article-title":"Synthesis, docking studies, and in silico ADMET predictions of some new derivatives of pyrimidine as potential KSP inhibitors","volume":"24","author":"Rashid","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117726_bib20","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1016\/j.bmc.2017.06.050","article-title":"Design and synthesis of potent and orally active GPR4 antagonists with modulatory effects on nociception, inflammation, and angiogenesis","volume":"25","author":"Miltz","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib21","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1016\/j.ejmech.2011.05.060","article-title":"New insights into the structural requirements for pro-apoptotic agents based on 2, 4-diaminoquinazoline, 2, 4-diaminopyrido [2, 3-d] pyrimidine and 2, 4-diaminopyrimidine derivatives","volume":"46","author":"Font","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1021\/acs.jmedchem.9b01618","article-title":"Synthesis and biological evaluation of B-cell lymphoma 6 inhibitors of N-phenyl-4-pyrimidinamine derivatives bearing potent activities against tumor growth","volume":"63","author":"Guo","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.mencom.2020.03.024","article-title":"Mono-and binuclear chloride complexes of bismuth (Iii) with 2-aminopyrimidine cations depending on specific synthetic route","volume":"30","author":"Trofimova","year":"2020","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.ejmech.2025.117726_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jphotobiol.2017.07.002","article-title":"Synthesis, single-crystal, DNA interaction, spectrophotometric and spectroscopic characterization of the hydrogen-bonded charge transfer complex of 2-aminopyrimidine with \u03c0-acceptor chloranilic acid at different temperature in acetonitrile","volume":"174","author":"Miyan","year":"2017","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.ejmech.2025.117726_bib25","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.bmcl.2017.05.085","article-title":"Design, synthesis, and structure\u2013activity relationships of pyrimido [4, 5-b] indole-4-amines as microtubule depolymerizing agents that are effective against multidrug resistant cells","volume":"27","author":"Devambatla","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117726_bib26","article-title":"Aminopyrimidines: recent synthetic procedures and anticancer activities","volume":"92","author":"Venturini Filho","year":"2021","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117726_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103811","article-title":"A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy","volume":"99","author":"Ayati","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22143","article-title":"2\u2010Thioxo\u20103, 4\u2010dihydropyrimidine and thiourea endowed with sulfonamide moieties as dual EGFRT790M and VEGFR\u20102 inhibitors: design, synthesis, docking, and anticancer evaluations","volume":"85","author":"El\u2010Gaby","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2025.117726_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100095","article-title":"Discovery of 4, 6\u2010Disubstituted pyrimidine derivatives as novel dual VEGFR2\/FGFR1 inhibitors","volume":"18","author":"Zhang","year":"2021","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2025.117726_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10637-021-01169-4","article-title":"Design, synthesis and biological evaluation of dual HDAC and VEGFR inhibitors as multitargeted anticancer agents","volume":"40","author":"Xue","year":"2022","journal-title":"Invest. New Drugs."},{"key":"10.1016\/j.ejmech.2025.117726_bib31","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/pr10071391","article-title":"The assessment of anticancer and VEGFR-2 inhibitory activities of a new 1 H-indole derivative: in silico and in vitro approaches","volume":"10","author":"Elkaeed","year":"2022","journal-title":"Processes"},{"key":"10.1016\/j.ejmech.2025.117726_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/molecules25040770","article-title":"Targeting receptor tyrosine kinase VEGFR-2 in hepatocellular cancer: rational design, synthesis and biological evaluation of 1, 2-disubstituted benzimidazoles","volume":"25","author":"Abdel-Mohsen","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117726_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2015.10.021","article-title":"Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes","volume":"103","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117726_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmech.2017.04.068","article-title":"Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors","volume":"136","author":"Abdullaziz","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115626","article-title":"Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: a contemporary perspective of SAR and molecular docking studies","author":"Moradi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11030-018-9875-7","article-title":"Synthesis of deuterium-enriched sorafenib derivatives and evaluation of their biological activities","volume":"23","author":"Zhong","year":"2019","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.117726_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/a-2157-5855","article-title":"A practical and efficient method for the synthesis of sorafenib and regorafenib","volume":"7","author":"Prachi","year":"2023","journal-title":"SynOpen"},{"key":"10.1016\/j.ejmech.2025.117726_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12964-020-00595-w","article-title":"ERK and akt exhibit distinct signaling responses following stimulation by pro-angiogenic factors","volume":"18","author":"Song","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2025.117726_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112457","article-title":"Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect","volume":"200","author":"Sana","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114041","article-title":"Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids","volume":"157","author":"Laborda-Illanes","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117726_bib41","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1016\/j.bmc.2010.05.063","article-title":"The design, synthesis, and evaluation of 8 hybrid DFG-Out allosteric kinase inhibitors: a structural analysis of the binding interactions of gleevec\u00ae, nexavar\u00ae, and BIRB-796","volume":"18","author":"Dietrich","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2017.12.089","article-title":"Amino acid conjugated antimicrobial drugs: synthesis, lipophilicity-activity relationship, antibacterial and urease inhibition activity","volume":"145","author":"Ullah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300320","article-title":"Identification of novel sulfathiazole\u2010triazolo\u2010chalcone hybrids as VEGFR\u20102\/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction","volume":"357","author":"Zeidan","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117726_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmech.2019.02.050","article-title":"Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors","volume":"168","author":"Zeidan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib45","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1021\/acsmedchemlett.3c00258","article-title":"Design, synthesis, and biological evaluation of SSE1806, a microtubule destabilizer that overcomes multidrug resistance","volume":"14","author":"Firdous","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117726_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107094","article-title":"Synthesis and characterization of bis-amide SSE1917 as a microtubule-stabilizing anticancer agent","volume":"143","author":"Iqbal","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib47","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1038\/s41598-018-21642-0","article-title":"Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance","volume":"8","author":"Manzoor","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117726_bib48","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/acs.jnatprod.1c01222","article-title":"Identification and characterization of natural and semisynthetic quinones as aurora kinase inhibitors","volume":"85","author":"Furqan","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.117726_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mod.2016.05.003","article-title":"The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model","volume":"141","author":"Ribatti","year":"2016","journal-title":"Mech. Dev."},{"key":"10.1016\/j.ejmech.2025.117726_bib50","series-title":"Protection of Animals Used for Scientific Purposes","first-page":"22\/09","author":"European","year":"2010"},{"key":"10.1016\/j.ejmech.2025.117726_bib51","first-page":"1","article-title":"Multifunctional electrospun nanofiber films of polyacrylonitrile and polyvinyl alcohol incorporating rhamnose and therapeutic agents for enhanced healing of infected burn wounds","author":"Ijaz","year":"2025","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ejmech.2025.117726_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115591","article-title":"SAR and lead optimization of (Z)-5-(4-hydroxy-3-methoxybenzylidene)-3-(2-morpholinoacetyl) thiazolidine-2, 4-dione as a potential multi-target antidiabetic agent","volume":"258","author":"Shah","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib53","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1039\/D4RA00766B","article-title":"Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation","volume":"14","author":"Hussain","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117726_bib54","doi-asserted-by":"crossref","first-page":"14742","DOI":"10.1039\/D4RA01536C","article-title":"Pregnenolone derivatives for the treatment of Alzheimer's disease: synthesis, and in vitro inhibition of amyloid \u03b2 1\u201342 peptide aggregation, acetylcholinesterase and carbonic anhydrase-II","volume":"14","author":"Tahir","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117726_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125558","article-title":"Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase","volume":"410","author":"G\u00fcle\u00e7","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejmech.2025.117726_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124169","article-title":"Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches","volume":"237","author":"Rehman","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2025.117726_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117327","article-title":"Promising thiazolidinedione-thiazole based multi-target and neuroprotective hybrids for Alzheimer's disease: design, synthesis, in-vitro, in-vivo and in-silico studies","author":"Hussain","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117726_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.879875","article-title":"Novel disease-associated missense single-nucleotide polymorphisms variants predication by algorithms tools and molecular dynamics simulation of human TCIRG1 gene causing congenital neutropenia and osteopetrosis","volume":"9","author":"Shinwari","year":"2022","journal-title":"Front. Mol. Biosci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500491X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500491X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:07:54Z","timestamp":1762265274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342500491X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"alternative-id":["S022352342500491X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117726","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bicyclic 2-aminopyrimidine derivatives as potent VEGFR-2 inhibitors and apoptosis Inducers: Structure-Guided design, synthesis, anticancer assessment, and in-silico exploration","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117726"}}